Operator: Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call. I would now like to turn the meeting over to Ms. Juli Miller.
Adaptimmune Therapeutics plc , a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company s pivotal Phase 2 data with afami-cel..
Adaptimmune Therapeutics PLC: Results of Adaptimmune s SPEARHEAD-1 Trial with Afami-cel in Advanced Sarcomas Published in the Lancet finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Sarcoma News healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Vancouver, British Columbia (Newsfile Corp. - November 24, 2021) - Quebec Silica Resources Corp. (CSE: QTZ) ("Quebec Silica," or the "Company") is pleased to announce that a phase of fieldwork has been